[1]
Wulandari Harahap, P., Putra Tarigan, S. and Novisari Soeroso, N. 2025. Adverse Event Of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment In Medan Among Pulmonary Adenocarcinoma: Focus On Non-Hematologic Toxicity. International Journal of Health and Pharmaceutical (IJHP). 5, 3 (Aug. 2025), 422–429. DOI:https://doi.org/10.51601/ijhp.v5i3.429.